undamentalytics Newsletter

Rezolute, Inc. insider trading

Every open-market purchase and sale by Rezolute, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.

Insider purchase Insider sale Marker size reflects trade value. Weekly closes adjusted for splits; may be delayed.
Rezolute, Inc. insider open-market trades
DateInsiderTrade SharesPriceValue 1M after 3M after 6M after

From insiders' Form 4 filings with the SEC: open-market purchases and sales only (awards, option exercises and shares withheld for tax are excluded), combined to one line per insider per day. "Plan" marks trades the filing says were made under a pre-set Rule 10b5-1 trading plan, which are scheduled in advance. Price changes run from the close on the trade date; hover a figure for the change relative to the S&P 500. Past moves don't predict future ones.

Does following Rezolute, Inc.’s insiders pay?

From September 6, 2012 to March 31, 2026, 11 insiders reported 76 open-market purchases and 2 sales not made under a pre-set plan in Rezolute, Inc. Twelve months after each purchase was reported, the shares were −100.3% against the S&P 500 on average (median −100.3%), over 1 purchase with a full year of prices; 0% beat the index. That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on October 15, 2020 into $3,635 by November 2, 2026, −15.5% a year. It held shares 17% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $15,875 (+8.0% a year), and held throughout $23,603 (+15.3%).

$0$10.0k$20.0k 2020202120222023202420252026 $23.6k$15.9k$3.6k
Copying Rezolute, Inc.'s insidersS&P 500, same days investedS&P 500, held throughout $10,000 copying every open-market purchase by Rezolute, Inc.'s insiders from October 15, 2020, before costs and taxes, marked weekly. Uninvested money earns the Treasury bill rate; the portfolio held shares 17% of the time.
Rezolute, Inc.: each insider's record
InsiderRolePurchases12 months after their purchasesBeat the S&P 500Sales12 months after their salesLatest report
Handok, Inc. and related entities Director 43 −100.3% (1) 0% 0 — March 19, 2024
Evans Daron CFO 11 — — 0 — March 31, 2026
Roberts Brian Kenneth Chief Medical Officer 7 — — 0 — December 17, 2025
Hogenhuis Wladimir Director 5 — — 0 — April 1, 2025
Kim Young-Jin Director 3 — — 0 — June 23, 2025
Welch David F Director 3 — — 0 — March 15, 2017
Elam Nevan C CEO 2 — — 0 — December 15, 2025
Bar Nir President and Treasurer 0 — — 1 — September 6, 2012
Karnawat Sunil Ratilal Chief Commercial Officer 1 — — 0 — December 15, 2025
Labrucherie Gil M Director 1 — — 0 — May 6, 2022
Wolkin Orit and related entities 10% owner 0 — — 1 — September 6, 2012

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.

← Back to Rezolute, Inc. · Funds · Politicians